Welcome to our dedicated page for AI / ML Innovations news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML Innovations stock.
AI/ML Innovations Inc. develops artificial intelligence and neural-network technology for digital health applications. The company’s platforms use signal processing and deep learning to convert biometric data into clinical insights, with recurring updates centered on ECG analysis, heart rate variability analytics, remote cardiac monitoring, and cardiovascular research support.
News for AIMLF also covers activity at its Neural Cloud Solutions subsidiary, including MaxYield™, CardioYield™, and Insight 360™ commercialization, reseller and distribution agreements, research-services collaborations, medical advisory board appointments, and capital-structure actions such as private placements, convertible debentures, warrants, options, and share issuances for debt settlement.
AI/ML Innovations Inc. (CSE: AIML, OTCQB: AIMLF) announced its participation in a live virtual presentation at VirtualInvestorConferences.com on August 5, 2021, at 11:30 AM ET. The event allows for real-time interaction between investors and the company, with an archived webcast available post-event. AI/ML Innovations focuses on acquiring AI and ML technologies, particularly in digital healthcare, having secured a 70% ownership in Health Gauge. Investors are encouraged to pre-register for the conference to enhance their experience.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) will present live at VirtualInvestorConferences.com on August 5th, 2021, at 11:30 AM EST. This interactive event will allow investors to engage with the company, asking questions in real-time. For those unable to attend, an archived version will be available. Investors are encouraged to pre-register and check their systems to ensure participation. AI/ML Innovations focuses on artificial intelligence and machine learning, particularly in digital healthcare.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced the appointment of Mr. Nicholas Watters to its Board of Directors, effective July 16, 2021. Watters brings extensive corporate governance experience and has previously raised nearly $260 million for startups in various industries. AI/ML focuses on artificial intelligence and machine learning technologies, particularly in digital health. The company aims to enhance stakeholder value through strategic partnerships and investments.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced the resignation of John Cook from its Board of Directors due to health concerns. The company acknowledged his significant contributions and wished him a successful recovery. AI/ML is focused on leveraging artificial intelligence and machine learning within digital health initiatives, partnering with firms like Health Gauge and Tech2Health to improve healthcare management. The company aims to capitalize on growth opportunities in these sectors.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) has partnered with Tech2Health to secure three multi-year contracts, projecting potential revenues of US$5 million over three years. These contracts allow access to 300,000 potential users for digital mental health services. Tech2Health will provide services like Qookka Live to major corporations and insurance providers in France, enhancing mental wellness support. This rapid commercialization within a month of product launch reflects a growing market for mental health services.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (DTC) in the U.S. This DTC eligibility enhances liquidity and accessibility for investors, allowing broader trading options across various brokerage firms. Tim Daniels, Chairman, emphasized the importance of this milestone for increasing stock liquidity and strengthening the company’s presence in U.S. markets. AIML is pursuing additional strategies for enhancing investor access, including potential up-listings.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) issued a correction regarding its contract with Volt Strategic Partners Ltd.. Initially, the company announced that Volt Strategic would provide market-making services, but clarified that Venture Liquidity Providers Inc. (VLP) is the actual market-maker. VLP's services, providing orderly trading for AIML shares, will cost $5,000 monthly for three months. Additionally, AIML will pay Volt Strategic $5,000 monthly for six months. Both agreements have termination clauses. AIML granted stock options for up to 100,000 shares at $0.80 per share.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced that its subsidiary Health Gauge has been selected for several prestigious US-based Accelerator Programs aimed at advancing digital health technology. Executive Chairman Tim Daniels highlighted this selection as a validation of Health Gauge's innovative technology. The programs include MATTER.health in Chicago, CELS-SFO in Silicon Valley, and Newchip in Austin, which provide invaluable networking opportunities and resources to enhance market presence. Health Gauge combines wearable health monitors with cutting-edge AI for improved healthcare outcomes.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has retained Volt Strategic Partners as a capital markets advisor and market-maker to enhance liquidity and orderly trading of its shares. The deal includes $5,000 monthly payments for six months, 50,000 stock options, and $75,000 worth of shares at market value. Additionally, TDM Financial will provide marketing solutions for $30,000 until October 27, 2021. These partnerships aim to grow the company’s value in the AI and digital healthcare sectors, following its acquisition of a 70% stake in Health Gauge.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced the launch of The Phoenix, a new wearable health monitoring device by its subsidiary Health Gauge. This advanced product features comprehensive health analytics including blood pressure, heart rate, and sleep monitoring, alongside new capabilities like blood-oxygen sensing and improved battery life. Priced at CAD$150, The Phoenix is designed to enhance user health management and is available for immediate purchase. The product launch coincides with the inventory depletion of the prior model, The Genesis.